Clinigen Drug Patent Portfolio
Clinigen owns 2 orange book drugs protected by 4 US patents Given below is the list of Clinigen's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727253 | Treatment of accidental extravasation of anthracyclines | 13 Mar, 2020 | Expired |
| US5994409 | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds | 08 Dec, 2017 | Expired |
| US5424471 | Crystalline amifostine compositions and methods of the preparation and use of same | 31 Jul, 2012 | Expired |
| US5591731 | Crystalline amifostine compositions | 31 Jul, 2012 | Expired |
Latest Legal Activities on Clinigen's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Clinigen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Petition Decision - Dismissed
Critical
| 05 Oct, 2016 | US6727253 |
|
Mail-Petition Decision - Dismissed
Critical
| 05 Oct, 2016 | US6727253 |
| Petition Entered | 04 Apr, 2016 | US6727253 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Sep, 2013 | US6727253 |
|
Correspondence Address Change
Critical
| 16 Sep, 2013 | US6727253 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Apr, 2004 | US6727253 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Apr, 2004 | US6727253 |
|
Issue Notification Mailed
Critical
| 08 Apr, 2004 | US6727253 |
| Receipt into Pubs | 18 Mar, 2004 | US6727253 |
|
Application Is Considered Ready for Issue
Critical
| 17 Mar, 2004 | US6727253 |
|
Issue Fee Payment Verified
Critical
| 05 Feb, 2004 | US6727253 |
|
Issue Fee Payment Received
Critical
| 05 Feb, 2004 | US6727253 |
| Receipt into Pubs | 12 Dec, 2003 | US6727253 |
| Dispatch to Publications | 09 Dec, 2003 | US6727253 |
|
Mail Notice of Allowance
Critical
| 05 Nov, 2003 | US6727253 |
Clinigen's Family Patents
Clinigen Drug List
Given below is the complete list of Clinigen's drugs and the patents protecting them.
1. Ethyol
Ethyol is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5994409 | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
08 Dec, 2017
(6 years ago)
| Expired |
| US5424471 | Crystalline amifostine compositions and methods of the preparation and use of same |
31 Jul, 2012
(12 years ago)
| Expired |
| US5591731 | Crystalline amifostine compositions |
31 Jul, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ethyol's drug page
2. Totect
Totect is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727253 | Treatment of accidental extravasation of anthracyclines |
13 Mar, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Totect's drug page